Market Research Report

A quick peek into the report

1.1 Role of Biomarkers in Cell Analysis
1.2 Recent Advancements in Cell Analysis
1.3 Trends for Latin America Cell Analysis Market
1.4 Cell Analysis Market: Future Potential
1.5 Latin America Cell Analysis Market Scenario

2.1 Impact Analysis
2.2 Market Drivers
2.2.1 Growing inclination towards single cell technology
2.2.2 Increasing focus on cell-based research across countries of Latin America
2.2.3 Increasing number of contract research organizations (CROs)
2.2.4 Rising awareness about regenerative medicine among individuals
2.2.5 Advancement in cell imaging and analysis technologies eased drug discovery process
2.3 Market Restraints
2.3.1 Stringent regulatory framework on cell analysis systems and assays
2.3.2 High costs associated with the cell analysis instruments
2.4 Market Opportunities
2.4.1 Offering of high-content screening services by contract research organizations (CROs)
2.4.2 Automation of cancer cell analysis techniques

3.1 Market Share Analysis
3.2 Industry Attractiveness
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyer
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products
3.2.5 Intensity of Competitive Rivalry

4.1 Instruments
4.1.1 Cell Imaging Systems and Microscopes
4.1.2 Flow Cytometer
4.1.3 Quantitative PCR (qPCR) Instruments
4.1.4 Cell Counters
4.1.5 Cell Screening and High-Content Screening Systems (HCS)
4.1.6 Other Instruments
4.2 Consumables
4.2.1 Assay Kits
4.2.2 Reagents
4.2.3 Other Consumables

5.1 Hospitals
5.2 Pharmaceutical and Biotechnology Companies
5.3 Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
5.4 Academic and Research Institutes
5.5 Other End User

6.1 Brazil
6.2 Mexico
6.3 Argentina
6.4 Chile
6.5 Colombia
6.6 Rest-of-Latin America (RoLA)

7.1 Overview
7.2 Becton, Dickinson and Company
7.2.1 Company Overview
7.2.2 Role of Becton, Dickinson and Company in the LATAM Cell Analysis Market
7.2.3 Overall Financials
7.2.4 Key Insights about Financial Health of the Company
7.2.5 SWOT Analysis
7.3 Bio-Rad Laboratories, Inc.
7.3.1 Company Overview
7.3.2 Role of Bio-Rad Laboratories, Inc. in LATAM Cell Analysis Market
7.3.3 Overall Financials
7.3.4 Key Insights about Financial Health of the Company
7.3.5 SWOT Analysis
7.4 Danaher Corporation
7.4.1 Company Overview
7.4.2 Role of Danaher Corporation in LATAM Cell Analysis Market
7.4.3 Overall Financials
7.4.4 Key Insights about Financial Health of the Company
7.4.5 SWOT Analysis
7.5 F.Hoffmann-La Roche AG
7.5.1 Company Overview
7.5.2 Role of F. Hoffmann-La Roche AG in the LATAM Cell Analysis Market
7.5.3 Overall Financials
7.5.4 Key Insights about Financial Health of the Company
7.5.5 SWOT Analysis
7.6 GE Corporation
7.6.1 Company Overview
7.6.2 Role of GE Corporation in the LATAM Cell Analysis Market
7.6.3 Overall Financials
7.6.4 Key Insights about Financial Health of the Company
7.6.5 SWOT Analysis
7.7 Merck & Co., Inc.
7.7.1 Company Overview
7.7.2 Role of Merck & Co., Inc. in the LATAM Cell Analysis Market
7.7.3 Overall Financials
7.7.4 Key Insights about Financial Health of the Company
7.7.5 SWOT Analysis
7.8 Olympus Corporation
7.8.1 Company Overview
7.8.2 Role of Olympus Corporation in LATAM Cell Analysis Market
7.8.3 Overall Financials
7.8.4 Key Insights about Financial Health of the Company
7.8.5 SWOT Analysis
7.9 Perkin Elmer, Inc.
7.9.1 Company Overview
7.9.2 Role of PerkinElmer, Inc. in the LATAM Cell Analysis Market
7.9.3 Overall Financials
7.9.4 Key Insights about Financial Health of the Company
7.9.5 SWOT Analysis
7.10 QIAGEN N.V.
7.10.1 Company Overview
7.10.2 Role of Qiagen N.V. in the Cell Analysis Market
7.10.3 Overall Financials
7.10.4 Key Insights on the Financial Health of the Company
7.10.5 SWOT Analysis
7.11 Sony Biotechnology Inc.
7.11.1 Company Overview
7.11.2 Role of Sony Biotechnology Inc. in the LATAM Cell Analysis Market
7.12 Thermo Fisher Scientific, Inc.
7.12.1 Company Overview
7.12.2 Role of Thermo Fisher Scientific Inc. in LATAM Cell Analysis Market
7.12.3 Overall Financials
7.12.4 Key Insights on the Financial Health of the Company
7.12.5 SWOT Analysis

8.1 Report Scope

Table 2.1: Impact Analysis

Figure 1: Cell Analysis Process
Figure 2: Latin America Cell Analysis Market Drivers and Restraints
Figure 3: Latin America Cell Analysis Market, 2017-2025
Figure 4: Latin America Cell Analysis Market (by Product Type), 2017 and 2025
Figure 5: Latin America Instruments Cell Analysis Market (by Type), 2017-2025
Figure 6: Latin America Cell Analysis Market (by End User), 2017-2025
Figure 7: Latin America Cell Analysis Market (by Country), 2017-2025
Figure 8: Insights Pertaining to the Cell Analysis Market Across Different Countries of Latin America
Figure 1.1: Global Cell Analysis Market Segmentation
Figure 1.2: Drug Development Process
Figure 1.3: Latin America Cell Analysis Market, 2017-2025
Figure 2.1: Market Dynamics of LATAM Cell Analysis Market
Figure 3.1: Market Share Analysis: Latin America Cell Analysis Market, 2016 and 2017
Figure 3.2: Porter’s Five Forces Analysis
Figure 3.3: Bargaining Power of Suppliers: Overall Impact, 2014-2025
Figure 3.4: Bargaining Power of Buyers: Overall Impact, 2014-2025
Figure 3.5: Threat of New Entrant: Overall Impact, 2014-2025
Figure 3.6: Threat of Substitute Products: Overall Impact, 2014-2025
Figure 3.7: Intensity of Competitive Rivalry: Overall Impact, 2014-2025
Figure 4.1: Some of The Strategies of Cell Therapy
Figure 4.2: Types of Cell Therapy
Figure 4.3: Types of Stem Cells
Figure 4.4: Latin America Cell Analysis Market (by Product Type)
Figure 4.5: Latin America Cell Analysis Market (by Product Type), 2017-2025
Figure 4.6: Latin America Cell Analysis Market (by Instruments), 2017-2025
Figure 4.7: Latin America Instruments Cell Analysis Market (by Cell Imaging Systems and Microscopes), 2017-2025
Figure 4.8: Latin America Instruments Cell Analysis Market (by Flow cytometer), 2017-2025
Figure 4.9: Latin America Instruments Cell Analysis Market (by Quantitative PCR Instruments), 2017-2025
Figure 4.10: Latin America Instruments Cell Analysis Market (by Cell Counters), 2017-2025
Figure 4.11: Latin America Instruments Cell Analysis Market (by Cell Screening and High-Content Screening Systems (HCS)), 2017-2025
Figure 4.12: Latin America Instruments Cell Analysis Market (by Other Instruments), 2017-2025
Figure 4.13: Latin America Cell Analysis Market (by Consumables), 2017-2025
Figure 4.14: Latin America Consumables Cell Analysis Market (by Type), 2017-2025
Figure 4.15: Latin America Consumables Cell Analysis Market (by Assay Kits), 2017-2025
Figure 4.16: Latin America Consumables Cell Analysis Market (by Reagents), 2017-2025
Figure 4.17: Latin America Consumables Cell Analysis Market (by Other Consumables), 2017-2025
Figure 5.1: Latin America Cell Analysis Market (by End User)
Figure 5.2: Latin America Cell Analysis Market (by End User), 2017-2025
Figure 5.3: Latin America Cell Analysis Market (by Hospitals), 2017-2025
Figure 5.4: Latin America Cell Analysis Market (by Pharmaceutical and Biotechnology Companies), 2017-2025
Figure 5.5: Latin America Cell Analysis Market (by Contract Research Organizations (CROs) and Contract Manufacturing Organization (CMOs), 2017-2025
Figure 5.6: Latin America Cell Analysis Market (by Academic and Research Institutes), 2017-2025
Figure 5.7: Latin America Cell Analysis Market (by Others), 2017-2025
Figure 6.1: Latin America Cell Analysis Market, 2017-2025
Figure 6.2: Latin America Cell Analysis Market (by Country), 2017-2025
Figure 6.3: Brazil Cell Analysis Market, 2017-2025
Figure 6.4: Mexico Cell Analysis Market, 2017-2025
Figure 6.5: Argentina Cell Analysis Market, 2017-2025
Figure 6.6: Chile Cell Analysis Market, 2017-2025
Figure 6.7: Colombia Cell Analysis Market, 2017-2025
Figure 6.8: Rest-of-Latin America Cell Analysis Market, 2017-2025
Figure 7.1: Shares of Key Company Profiles
Figure 7.2: Becton, Dickinson and Company: Product Offerings
Figure 7.3: Becton, Dickinson and Company: Overall Financials, 2015-2017
Figure 7.4: Becton, Dickinson and Company: Revenue (by Segment), 2015-2017
Figure 7.5: Becton, Dickinson and Company: Revenue Split for BD Life Sciences, 2015-2017
Figure 7.6: Becton, Dickinson and Company: Revenue (by Region), 2015-2017
Figure 7.7: Becton, Dickinson and Company: R&D Expenditure, 2015-2017
Figure 7.8: Becton, Dickinson and Company: SWOT Analysis
Figure 7.9: Bio-Rad Laboratories, Inc.: Product Offerings
Figure 7.10: Bio-Rad laboratories, Inc.: Overall Financials, 2015-2017
Figure 7.11: Bio-Rad Laboratories, Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.12: Bio-Rad Laboratories, Inc.: Revenue (by Region), 2015-2017
Figure 7.13: Bio-Rad Laboratories, Inc.: R&D Expense, 2015-2017
Figure 7.14: Bio-Rad Laboratories, Inc.: SWOT Analysis
Figure 7.15: Danaher Corporation: Product Offerings
Figure 7.16: Danaher Corporation: Overall Financials, 2015-2017
Figure 7.17: Danaher Corporation: Revenue (by Segment), 2015-2017
Figure 7.18: Danaher Corporation: Revenue (by Region), 2015-2017
Figure 7.19: Danaher Corporation: R&D Expenditure, 2015-2017
Figure 7.20: Danaher Corporation: SWOT Analysis
Figure 7.21: F. Hoffmann-La Roche AG: Product Offerings
Figure 7.22: F. Hoffmann-La Roche AG: Overall Financials, 2015-2017
Figure 7.23: F. Hoffmann-La Roche AG: Revenue (by Segment), 2015-2017
Figure 7.24: F. Hoffmann-La Roche AG: Revenue (by Region), 2015-2017
Figure 7.25: F. Hoffmann-La Roche AG: R&D Expenditure, 2015-2017
Figure 7.26: F. Hoffmann-La Roche AG: SWOT Analysis
Figure 7.27: GE Corporation: Product Offerings
Figure 7.28: GE Corporation Limited: Overall Financials, 2015-2017
Figure 7.29: GE Corporation: Revenue (by Business Segment), 2015-2017
Figure 7.30: GE Corporation: Revenue (by Region), 2015-2017
Figure 7.31: GE Corporation R&D Expenditure, 2014-2017
Figure 7.32: GE Corporation: SWOT Analysis
Figure 7.33: Merck KGaA: Product Offerings
Figure 7.34: Merck & Co., Inc.: Overall Financials, 2015-2017
Figure 7.35: Merck & Co., Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.36: Merck & Co., Inc.: Revenue (by Region), 2015-2017
Figure 7.37: Merck & Co., Inc. R&D Expenditure, 2015-2017
Figure 7.38: Merck & Co., Inc.: SWOT Analysis
Figure 7.39: Olympus Corporation: Overall Financials, 2015-2017
Figure 7.40: Olympus Corporation: Revenue (by Business Segment), 2015-2017
Figure 7.41: Olympus Corporation: Revenue (by Region), 2015-2017
Figure 7.42: Olympus Corporation R&D Expenditure, 2015-2017
Figure 7.43: Olympus Corporation: SWOT Analysis
Figure 7.44: PerkinElmer, Inc.: Product Offerings
Figure 7.45: PerkinElmer, Inc.: Overall Financials, 2015-2017
Figure 7.46: PerkinElmer, Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.47: PerkinElmer, Inc.: Revenue (by Region), 2015-2017
Figure 7.48: PerkinElmer, Inc. R&D Expenditure, 2015-2017
Figure 7.49: PerkinElmer, Inc.: SWOT Analysis
Figure 7.50: Qiagen N.V.: Overall Financials, 2015-2017
Figure 7.51: Qiagen N.V.: Revenue (by Business Segment), 2015-2017
Figure 7.52: Qiagen N.V.: Revenue (by Region), 2015-2017
Figure 7.53: Qiagen N.V.: R&D Expense, 2015-2017
Figure 7.54: Qiagen N.V.: SWOT Analysis
Figure 7.55: Sony Biotechnology Inc.: Product Offerings
Figure 7.56: Thermo Fisher Scientific Inc.: Product Offerings
Figure 7.57: Thermo Fisher Scientific Inc.: Overall Financials, 2015-2017
Figure 5.58: Thermo Fisher Scientific Inc.: Revenue (by Business Segment), 2015-2017
Figure 7.59: Thermo Fisher Scientific Inc.: Revenue (by Region), 2015-2017
Figure 7.60: Thermo Fisher Scientific Inc.: R&D Expense, 2015-2017
Figure 7.61: Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 8.1: Latin America Cell analysis: Market Segmentation
Figure 8.2: Reserach Methodology
Figure 8.3: Primary Research
Figure 8.4: Secondary Research
Figure 8.5: Data Triangulation
Figure 8.6: Top-down Approach (Segment-wise Analysis)
Figure 8.7: Bottom-up Approach (Segment-wise Analysis)
Figure 8.8: Assumptions and Limitations
Figure 8.9: Considered Factors for Data Prediction and Modelling

Key Questions Answered in this Report:

• What are the key features of the cell analysis technology promoting its incorporation in different clinical applications?
• What are the processes involved in cell analysis?
• What are the major market drivers, challenges, and opportunities in Latin America cell analysis market?
• Which are the leading companies dominating the Latin America cell analysis market?
• What are investors’ perceptions about the Latin America cell analysis market?
• What was the market value of the leading segments and sub-segments of the Latin America cell analysis market?
• How will each segment of the Latin America cell analysis market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
• How will the industry evolve during the forecast period 2019-2025?
• Which country will register the highest sales in Latin America during the forecast period?

Market Overview

Technological innovations in the healthcare industry have opened up new avenues for better treatment, and prevention approaches, for infectious and non-infectious diseases globally. The changes and innovations in the healthcare industry have changed the experiences of patients, outcomes of chronic diseases, and improved practices of healthcare professionals. A significant degree of research on molecular technologies and cellular biomarkers presence in body fluids have opened various pathways for the development of cellular heterogeneity analysis and molecular level analysis of pathways and processes.

The cells constitute distinct units of biological functions, and analyzing cells helps identify and map the biochemical and physical processes of the life of a patient. Compiling data sets from the multiple cell analysis investigations help the scientists get a better understanding, and predict the influence of, factors that lead to changes in the cell proliferation, cell health, cell function, and cell death in a human body. Also, analysis of cells plays a major role in the gene identification process, epigenomics, and related areas of life-science that focus on the study of genotypical and phonotypical characteristics of the cells. Certain treatments for infectious diseases delay disease progression and the onset of associated complications. With the rising geriatric population that’s more prone to illness and the increasing prevalence of the chronic diseases, the modern age medicine needs to include proper analysis, as well as alternative therapies for the treatment of such conditions in affected patients. These factors are also prerequisites for an improved quality of life of the patients after they have been cured.

The purpose of this study is to gain a holistic view of the Latin America cell analysis market in terms of various influencing factors such as recent trends, regulatory frameworks, and technological advancements in the market. The scope of this report constitutes a detailed study of the different kinds of products associated with the Latin America cell analysis market. The market has been segmented into “Product Type”, “End User”, and “Country”. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025. Some of the factors such as growing inclination towards single-cell technology, increasing prevalence of chronic diseases, technological advancements of cell analysis instruments, increasing support from governments of countries in Latin America for cell-based research activities, and increasing number of contract research organizations providing outsourcing services are bolstering the growth of the Latin America cell analysis market.

In terms of product type, the Latin America cell analysis market is dominated by consumables. The impressive growth in the demand for consumables, which includes assays, reagents and labeling kits, among others, is attributed to the elevated requirement for specialty chemicals and assays intended for research activities and therapeutic purposes. Further, the installation of new cell analysis units and replacement of old ones is bolstering the growth of the Latin America cell analysis market. Cell-based flow cytometry is a major domain that is gaining popularity owing to its ease of use, high accuracy, and sensitivity. Increasing awareness pertaining to the use of cell-based assays is further supporting the use of cell-based flow cytometer.

In terms of end user, the Latin America cell analysis market is dominated by pharmaceutical and biotechnology companies. The growth can be accounted to the increased awareness and adoption of cell analysis tests for an early detection and treatment of infectious diseases. The shift from chemical-based small molecules to the biology-based larger molecules such as protein and antibodies is supporting the growth of the pharmaceutical and biotechnology companies’ segment. Latin America majorly focuses on research for the development of relevant drugs and providing vital real-time information on tumor profiles and chronic diseases, further facilitating the prognosis and treatment approach for healthcare professionals.

In terms of country, Brazil is the leading contributor to the Latin America cell analysis market. The growing geriatric population and rising prevalence of different types of cancer have significantly elevated the requirement of novel cell analysis technologies which enable real-time monitoring, diagnosis, and prognosis in the country.

The key players who have been contributing significantly to the Latin America cell analysis market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, GE Corporation, Merck & Co., Inc., Olympus Corporation, PerkinElmer, Inc., Qiagen N.V., Sony Biotechnology Inc., and Thermo Fisher Scientific Inc.

Report Description

Cell analysis is predominantly applied in therapeutics for several chronic and infectious diseases such as diabetes, cancer, obesity, hepatitis B, and HIV. Cell analysis includes assessment of discrete biological functions such as evaluation of cells and interactions amongst the cells, and the procedure is different from an organ, tissue, as well as cell culture. Such an assessment enables acquisition of crucial information on, and helps comprehend, the fundamental biochemical and physical processes of life. The assessment obtained from cell analysis, therefore, helps physicians and researchers in acknowledging, envisaging, and manipulating the factors responsible for health, proliferation, function, and death of a cell. The principal cell analysis techniques are cell signaling pathway analysis, cell viability, cell identification, cell proliferation analysis, single-cell analysis, target identification and validation, cell counting and quality control, cell structure study, and cell interaction analysis. Amongst these, single-cell analysis is one of the emerging techniques of cell analysis. The single cell analysis enables cellular heterogeneity analysis and molecular level analysis of pathways and processes, the single-cell analysis technique is enticing interest of several researchers worldwide.

The purpose of this study is to gain a holistic view of the Latin America cell analysis market in terms of various influencing factors such as recent trends, regulatory frameworks, and technological advancements in the market. The scope of this report constitutes a detailed study of the different kinds of products associated with the Latin America cell analysis market. The market has been segmented into “Product Type”, “End User”, and “Country”. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps process well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration by the industry players before entering the market.

The research aims at answering various aspects of the Latin America cell analysis market, by analyzing the key factors that drive, restrain, and challenge the market, in chapter focussed on market dynamics, and studies the current opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market.

The research study highlights the factors governing the industry attractiveness derived through Porter’s Five Forces Analysis for a comprehensive understanding of the Latin America cell analysis market. Moreover, the study includes detailed product mapping, market estimation, and analysis of key trends in multiple regions, growth of cell analysis market in each region for different cancer types, and the key strategies and developments by the prominent cell analysis market stakeholders.

The report also includes detailed information on the key players who have been contributing significantly to the Latin America cell analysis market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche AG, GE Corporation, Merck & Co., Inc., Olympus Corporation, PerkinElmer, Inc., Qiagen N.V., Sony Biotechnology Inc., and Thermo Fisher Scientific Inc..